好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Use of Computer Vision to Estimate Spatiotemporal Gait Measures From Consumer Grade Videos in People With Multiple Sclerosis
Multiple Sclerosis
P4 - Poster Session 4 (8:00 AM-9:00 AM)
18-010

To assess the validity of an algorithm that estimates spatiotemporal gait parameters in people with MS (PwMS) using only a single consumer-grade video.

Gait analysis in PwMS typically requires expensive tools, such as motion capture or pressure mats. In contrast, pose estimation software provides a low-cost, accessible method to collect kinematic data. 

153 adult PwMS were recorded with a single consumer-grade camera in the frontal plane while walking as fast as safely possible; among these, videos from a second timepoint were available for 73 participants. Videos were processed using MediaPipe Pose pose estimation software. A custom-written algorithm then calculated the following gait parameters: an estimate of walking speed, stride time, cadence, and stride width. Additionally, Timed-25 Foot Walk (T25FW) was collected.

Linear mixed-effect models were used to assess the cross-sectional association of FW video-derived gait parameters with log-transformed T25FW. Descriptive statistics were used to evaluate the longitudinal validity of video-derived parameters compared to T25FW.

In a multivariate model, older age (Estimate 0.0048 [0.0019, 0.0078], p=0.002), slower walking speed estimate (-0.26 [-0.33, -0.19], p<0.001), and longer stride time (0.97 [0.75, 1.2], p<0.001) were associated with slower walking by T25FW. These three variables predicted a majority of variance in log-transformed T25FW (conditional R2 0.79, marginal R2 0.63).

In preliminary longitudinal analysis, when evaluated categorically (worsening defined as: ≥ 20% increase in T25FW and worsening in either video-derived parameter ≥ smallest real difference), the change in these two video-derived parameters agreed with the change in T25FW in 83% of participants.

This study demonstrates the initial validity of pose estimation to extract valid, longitudinally informative gait parameters from consumer-grade videos in PwMS. Computer vision shows promise as an accessible, low-cost evaluation of patient gait without the requirement of high-end equipment or trained personnel.
Authors/Disclosures
Megan McCune, PhD
PRESENTER
Dr. McCune has nothing to disclose.
Yoni Ackerman, SPT Mr. Ackerman has nothing to disclose.
Nikki Sisodia (University of California San Francisco) Nikki Sisodia has nothing to disclose.
Kyra Henderson (UCSF) Kyra Henderson has nothing to disclose.
Jaeleene Wijangco Jaeleene Wijangco has nothing to disclose.
Shane Poole (UCSF) Shane Poole has nothing to disclose.
Abel Torres Espin No disclosure on file
Elzbieta D. Miller Prof. Miller has nothing to disclose.
Valerie A. Block, DPTSc (University of California, San Francisco) Dr. Block has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Block has received research support from National MS Society.
Riley Bove, MD, FAAN (University of California, San Francisco) Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.